Angiosarcoma
📧 Sign up to get email alerts when something new happens for Angiosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study [Phase 2]
Phase 2 trial results for sintilimab in locally advanced, metastatic, or recurrent angiosarcoma are posted; the study is terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma [Phase 2]
Phase 2 clinical trial update of the combination of oleclumab and durvalumab for recurrent, refractory, or metastatic sarcoma, including ang…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors [Phase 2]
This Phase 2 trial update describes testing nivolumab plus ipilimumab in patients with a broad set of rare tumors and notes the study status…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas [Phase 2]
Phase 2 trial evaluating weekly paclitaxel with or without bevacizumab in metastatic or locally advanced angiosarcoma has completed and repo…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer [Phase 1]
Phase 1 clinical trial evaluating MQ710 with and without pembrolizumab in solid tumors; the study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures [Phase 4]
A Phase 4 trial evaluating the safety and effectiveness of a Lipiodol Ultra Fluid and glue mixture for embolization procedures in congenital…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study [Phase 2]
A Phase 2 clinical trial (SiARa Cancer Study) evaluating Sintilimab for locally advanced, metastatic, or recurrent angiosarcoma has been ter…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE) [Phase 2]
Phase 2 clinical trial of eribulin in angiosarcoma and epithelioid hemangioendothelioma has posted results.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Cemiplimab for Secondary Angiosarcomas [Phase 2]
This report indicates the completion of a Phase 2 trial evaluating cemiplimab for secondary angiosarcoma and related locally advanced or met…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma [Phase 2]
Phase 2 trial evaluating albumin-bound paclitaxel with liposomal doxorubicin for advanced or unresectable angiosarcoma.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Propranolol in Angiosarcoma [Phase 2]
Phase 2 clinical trial investigating propranolol for angiosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma [Phase 2]
Phase 2 trial of pazopanib hydrochloride in advanced angiosarcoma has completed and results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Evaluation of Votrient in Angiosarcoma [Phase 2]
Phase 2 trial evaluating Votrient (pazopanib) in angiosarcoma; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas [Phase 2]
Phase 2 trial update for axitinib in advanced angiosarcoma and other soft tissue sarcomas has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma [Phase 2]
Phase 2 trial evaluating daily oral regorafenib in chemotherapy-refractory, metastatic, and locally advanced angiosarcoma; study completed w…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma [Phase 3]
Phase 3 trial comparing TRC105 plus pazopanib versus pazopanib alone in advanced angiosarcoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Bevacizumab in Treating Patients With Angiosarcoma [Phase 2]
Phase 2 trial evaluating bevacizumab for angiosarcoma has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-26Clinical Trial Update: Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma [Phase 2]
A Phase 2 trial of paclitaxel plus bevacizumab for metastatic or unresectable angiosarcoma has been terminated, with results posted in March…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma [Phase 2]
Phase 2 clinical trial update for romidepsin (depsipeptide) in patients with metastatic or unresectable soft tissue sarcoma, with results po…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial update evaluating paclitaxel for locally advanced or metastatic soft tissue angiosarcoma or lymphangiosarcoma that cannot be r…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating vismodegib with RO4929097 targeting Hedgehog and Notch pathways in various advanced/metastatic soft tissue …
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma [Phase 1]
This Phase 1 trial evaluated the combination of cixutumumab and doxorubicin in patients with unresectable, locally advanced, or metastatic s…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes [Phase 2]
A Phase 2 trial evaluated the combination of gemcitabine, docetaxel, and bevacizumab in selected sarcoma subtypes, including leiomyosarcoma …
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery [Phase 2]
This Phase 2 trial evaluated trebananib in patients with advanced angiosarcoma unsuitable for surgical resection; the study has completed an…